Prostate cancer is a prevalent cancer among men globally, and its prognosis is influenced by various factors, including age. Age plays a significant role in determining survival rates for prostate cancer patients. By exploring the relationship between age and survival outcomes, we can enhance patient care and make informed treatment decisions. Furthermore, advancements in pharmacological therapies have revolutionized the management of prostate cancer, offering improved prospects for patients.
